2012
DOI: 10.1016/j.ajme.2011.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical expression of CD44v6 in differentiated thyroid carcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…23 El-Gendi et al reported that papillary thyroid carcinoma (PTC; n ¼ 30) showed higher CD44v6 expression than follicular thyroid carcinoma (n ¼ 10). 24 On the contrary, downregulation of the CD44 gene was associated with a poor prognosis of laryngeal carcinoma. 25 Age and gender did not show any significant association with CD44 expression.…”
Section: Discussionmentioning
confidence: 99%
“…23 El-Gendi et al reported that papillary thyroid carcinoma (PTC; n ¼ 30) showed higher CD44v6 expression than follicular thyroid carcinoma (n ¼ 10). 24 On the contrary, downregulation of the CD44 gene was associated with a poor prognosis of laryngeal carcinoma. 25 Age and gender did not show any significant association with CD44 expression.…”
Section: Discussionmentioning
confidence: 99%